Non-CME Educational Activities

All events are scheduled during times that do not conflict with Symposium CME educational programing.

These optional non-CME educational activity and are not approved for CME or continuing education credit. The content of these optional non-CME activities and opinions expressed by presenters are those of the sponsor or presenters.

---

Peer insights to help identify and manage candidates for treatment with a CDK4/6 inhibitor

Thursday, October 23 • lunch event

Presenter: Kelly McCann, MD, PhD, UCLA

sponsored by Eli Lilly

---

A 2L Treatment Option for HR+/HER2- aBC or mBC With PIK3CA, AKT1, or PTEN Alterations Following Progression on or After ET ± CDK4/6i

Friday, October 24 • lunch event

Presenter: Kit Lu, MD, UPMC Hillman Cancer Center

sponsored by AstraZeneca

---

Offering an ADC Treatment for Patients With Pretreated HR+/HER2- mBC and mTNBC

Saturday, October 25 • lunch event

Presenter: Neil Iyengar, MD, Emory University

sponsored by Gilead